Robust growth, reasonably priced
Pune-based Foseco India has a portfolio of over 400 complex...
Sangam India will operate two toll stations at Chirle and Karanjade near Mumbai
Sangam (India) said it has bagged a contract worth Rs63 crore from National Highways Authority of India (NHAI) for toll road collection at Panvel, in Mumbai.
“Sangam (India)... has bagged a project worth Rs63 crore from NHAI for toll road collection at Panvel, JNPT section of NH 4B,” the company said in a filing to the BSE. The company said it will operate two toll stations at Chirle and Karanjade.
Sangam Group is also one of the largest manufacturers of polyester viscose dyed yarn in the country.
In the late afternoon, Sangam (India) was trading at around Rs35.50 per share on the Bombay Stock Exchange, 1.66% down from the previous close.
Lincoln Pharmaceuticals is the first company in India to introduce a cure for tinnitus as Tinnex injection using Caroverine. The Caroverine injection was developed under research and development collaboration with Phafag AG, Switzerland
Lincoln Pharmaceuticals (LPL) has entered into an agreement with Phafag AG, Switzerland, for its Caroverine molecule for the treatment of tinnitus, commonly known as ‘ringing in the ear’. In chronic cases, the inner hair cells get damaged causing continuous depression, anxiety and insomnia in patients. Millions of people around the world suffer from tinnitus.
LPL is the first company in India to introduce a cure for tinnitus as Tinnex injection using Caroverine. Tinnex injection is a slow intravenous infusion. The dosage differs from patient and depends on the severity. The Caroverine injection was developed under research and development collaboration with Phafag AG, Switzerland.
Mahendra G Patel, MD, LPL, said: “With the amount of people suffering from tinnitus, it was very sad that no effort was being made to alleviate the discomfort and pain caused to patients. Now with the Tinnex injection being readily available, it is certainly going to be a boon for many. We at LPL are very happy to be a part of the solution.’
In the late afternoon, Lincoln Pharmaceuticals was trading at around Rs29.50 per share on the Bombay Stock Exchange, 7.66% up from the previous close.